Frontage is a global CRO advancing drug discovery and development with a comprehensive portfolio of genomics services. We deliver accurate and in-depth analyses to move compounds through early discovery and preclinical studies and for translational and clinical programs.

​Frontage has developed a next-generation sequencing (NGS)-based method to rapidly determine the genotype of 300+ genes involved in ADME, called the Frontage PGx NGS Test.

In this podcast, we discuss the importance of understanding the role of Safety Pharmacology in your IND filing with special guest: Chris Elders, Study Director at Frontage Laboratories, Inc.